ALLMedicine™ Alcohol Use Disorder Center
Research & Reviews 1,104 results
https://doi.org/10.1007/s12640-021-00418-x 10.1002/JLB.3A1218-476RR 10.1124/mol.115.102301 10.3389/fneur.2019.00663 10.1038/s41380-020-00970-6 10.1159/000510414 10.1152/physrev.00018.2018 10.1039/D0FO01483D 10.3389/fncel.2019.00162 10.1016/j.ejphar.2018.07.043 10.1111/jnc.15284 10.1007/s12640-020-00238-5 10.1007/s12640-018-9913-3 10.3390/jcm10030541 10.1124/mol.114.093294 10.3389/fendo.2014.00081 10.1111/nmo.13157 10.1097/JCP.0000000000001364 10.1073/pnas.1016088108 10.1124/pharmrev.120.000083 10.3390/nu11092216 10.1016/j.jns.2017.08.3235 10.1186/s12974-018-1328-9 10.1007/s00213-019-05232-0 10.1016/0277-5379(87)90109-X 10.3390/nu13051591 10.2174/1381612826666200122153541 10.3390/ijms22115830 10.1016/j.neuroscience.2013.04.037 10.1038/s41598-019-43502-1 10.1007/164_2016_52 10.1007/s12640-021-00375-5 10.3389/fendo.2012.00111 10.3390/nu13041115 10.1016/j.advms.2021.05.003 10.1159/000516398 10.21037/atm-21-2158
Neurotoxicity Research; Getachew B, Csoka AB et. al.
Sep 24th, 2021 - Alcohol use disorder (AUD), brought about by excessive alcohol use, is associated with damages to several organs including the brain. Chronic excessive use of alcohol can compromise intestinal integrity, leading to changes in gut microbiota (GM) c...
https://doi.org/10.1007/s12640-021-00416-z 10.1542/peds.106.1.158 10.1152/jappl.1992.72.6.2099 10.1081/JA-200066866 10.1111/j.1360-0443.2006.01423.x 10.1111/j.1476-5381.2009.00186.x 10.1056/NEJMra011089 10.1080/10826080500411528 10.1001/jama.1987.03400060056021 10.1111/j.0953-816X.2004.03453.x 10.1016/j.forsciint.2019.03.047 10.1017/S1049023X17007099 10.1016/j.brainres.2006.06.087 10.2215/CJN.02080508 10.1152/physrev.00015.2003 10.1016/j.ejphar.2007.06.006 10.1016/j.alcohol.2004.09.003 10.1038/sj.npp.1300714 10.1038/s41598-021-85389-x 10.1007/s002130050908 10.1038/sj.bjp.0701859 10.1007/s002130100762 10.1038/sj.bjp.0702373 10.1016/S0163-7258(03)00003-2 10.2165/00007256-200434010-00002 10.1007/BF02249342 10.1016/0031-9384(95)00136-7 10.4161/23328940.2014.985953 10.1002/(SICI)1099-1077(199705/06)12:3<221::AID-HUP854>3.0.CO;2-C 10.1016/S0006-8993(00)02308-8 10.1097/00007691-200404000-00009 10.1159/000253553 10.1007/BF02376775 10.1111/j.1476-5381.2010.00722.x 10.1001/jama.1987.03390120077027 10.1177/0269881108100020 10.1177/0269881106063271 10.1152/ajpregu.1982.242.5.R522 10.1111/j.1749-6632.2002.tb04181.x 10.1211/0022357011777855 10.1007/s00213-005-0149-6 10.1139/h99-016 10.1016/j.jemermed.2009.05.001 10.7326/0003-4819-73-1-81 10.1016/0091-3057(91)90288-D 10.1007/s00421-019-04283-7 10.1301/nr.2003.aug.261-271 10.1016/j.ejphar.2004.07.006 10.1007/s00213-003-1725-2 10.1017/S1481803500012598 10.1093/bja/ael078 10.1007/s00213-007-0752-9 10.1016/j.pbb.2006.04.023 10.1007/s00213-007-1007-5 10.1093/qjmed/95.7.431 10.1136/bmj.305.6844.5 10.1016/S0140-6736(05)78744-4 10.1016/0140-6736(92)91469-O 10.1007/s00213-004-2030-4 10.1136/emermed-2012-202174 10.1016/S0741-8329(97)00136-5 10.1111/j.1476-5381.2012.01936.x 10.1007/s00213-006-0602-1 10.1016/0163-7258(83)90018-9 10.1016/j.drugalcdep.2009.05.016 10.1016/j.drugalcdep.2008.04.001 10.1111/j.1465-3362.2011.00348.x 10.1093/brain/awq103 10.1523/JNEUROSCI.0506-14.2014 10.1038/npp.2015.182 10.1111/j.1748-1716.1992.tb09276.x 10.4161/23328940.2014.955433 10.1007/s002130000648 10.1523/JNEUROSCI.18-13-05086.1998 10.1038/426403a 10.1007/s00109-004-0591-7 10.1016/j.pbb.2011.06.032 10.1152/jappl.1992.73.4.1340 10.1111/j.1360-0443.2011.03399.x 10.1016/j.drugpo.2019.07.005 10.1080/17425255.2020.1749262 10.1016/j.drugalcdep.2011.08.012 10.1002/hup.773 10.1016/j.jemermed.2005.05.007 10.1523/JNEUROSCI.21-21-08648.2001 10.1001/archinte.1963.03860020052002 10.1007/s00213-011-2598-4 10.1097/00003246-198611000-00011 10.1172/JCI103092 10.1016/j.neuroscience.2008.04.041 10.1124/jpet.104.079236 10.1007/s00213-004-2106-1 10.1177/026988110401800312 10.1152/jappl.1985.59.5.1394 10.1007/s00213-003-1730-5 10.1002/hup.528 10.1097/EJA.0b013e32835a1127 10.1172/JCI105900 10.1177/0269881121991792 10.1152/jappl.1997.83.4.1152 10.1038/sj.bjp.0705823 10.1097/01.CCM.0000165969.29002.70 10.1016/B978-0-444-64074-1.00036-7 10.1097/00063110-199909000-00014 10.1007/s00213-014-3759-z 10.1111/j.1365-2044.1993.tb07072.x 10.1016/S0376-8716(99)00002-2 10.1177/0269881119897559 10.1093/ndt/gft023 10.1007/s00213-010-1864-1 10.1111/j.1476-5381.2012.02065.x 10.1080/10408444.2020.1867822 10.1136/emj.15.5.322 10.1016/S0376-8716(00)00215-5 10.1074/jbc.272.52.32847
Neurotoxicity Research; van Amsterdam J, Brunt TM et. al.
Sep 24th, 2021 - Although MDMA (ecstasy) is a relatively safe recreational drug and is currently considered for therapeutic use for the treatment of posttraumatic stress disorder (PTSD) and alcohol use disorder (AUD), recreational MDMA use occasionally elicits hyp...
https://doi.org/10.1093/alcalc/agab065
Alcohol and Alcoholism (Oxford, Oxfordshire); Li J, Xu K et. al.
Sep 24th, 2021 - Increasing preclinical and clinical reports have demonstrated the efficacy of gabapentin (GBP) in treating alcohol use disorder (AUD). However, the mechanism of the effects of GBP in AUD is largely unknown. Herein, we sought to investigate the eff...
https://www.ncbi.nlm.nih.gov/pubmed/34546909
Journal of Studies on Alcohol and Drugs; Eddie D, Barr M et. al.
Sep 22nd, 2021 - Although stress is a well-known predictor of alcohol use lapses among individuals seeking recovery from alcohol use disorder (AUD), most research has relied on retrospective self-report using conventional questionnaires that explore stress effects...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8449879
BMC Psychiatry; Khemiri L, Brynte C et. al.
Sep 20th, 2021 - Impulsivity is associated with several psychiatric disorders, including substance use disorders (SUD) and attention deficit hyperactivity disorder (ADHD). A widely used questionnaire to assess impulsivity is the Barratt Impulsiveness Scale (BIS), ...
Guidelines 1 results
https://doi.org/10.1007/s11739-018-1933-8
Internal and Emergency Medicine; Caputo F, Agabio R et. al.
Sep 7th, 2018 - The chronic use of alcohol can lead to the onset of an alcohol use disorder (AUD). About 50% of subjects with an AUD may develop alcohol withdrawal syndrome (AWS) when they reduce or discontinue their alcohol consumption and, in 3-5% of them, conv...
Clinicaltrials.gov 1 results
https://clinicaltrials.gov/ct2/show/NCT02492334
Jan 3rd, 2020 - As a result of sustained operations in Afghanistan and Iraq, there are an increasing number of U.S. military personnel and Veterans at risk of developing both posttraumatic stress disorder (PTSD) and an alcohol use disorder (AUD). If left untreate...
News 34 results
https://www.medscape.com/viewarticle/944535
Jan 22nd, 2021 - Naltrexone reduces the risk for hospitalization for alcohol use disorder (AUD), regardless of whether it is used alone or in conjunction with disulfiram or acamprosate, new research suggests. Investigators analyzed 10-year data on more than 125,00...
https://reference.medscape.com/viewarticle/936600_1
Sep 2nd, 2020 - Alcohol use is the third-leading cause of preventable death in the United States. The World Health Organization (WHO) estimates that the harmful use of alcohol results in about 3 million deaths worldwide each year, which is 5.3% of all deaths. Alc...
https://reference.medscape.com/viewarticle/936600
Sep 2nd, 2020 - Alcohol use is the third-leading cause of preventable death in the United States. The World Health Organization (WHO) estimates that the harmful use of alcohol results in about 3 million deaths worldwide each year, which is 5.3% of all deaths. Alc...
https://www.medscape.com/viewarticle/930047
May 6th, 2020 - As alcohol-related death and disease rates rise, framing alcohol use disorder as a treatable disease with neurobiologic underpinnings might help reduce the stigma that many patients endure, according to George F. Koob, PhD, director of the Nationa...
https://www.staging.medscape.com/viewarticle/930047
May 6th, 2020 - As alcohol-related death and disease rates rise, framing alcohol use disorder as a treatable disease with neurobiologic underpinnings might help reduce the stigma that many patients endure, according to George F. Koob, PhD, director of the Nationa...
